Get the app!
Back to Trades

Slover Peter T

Chief Financial OfficerCIK 0001468012

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
1
Buy transactions
0
Sell transactions
0
Companies
1
Active
2026

Across 1 filing between 2026, Slover Peter T, Chief Financial Officer, has disclosed $2.7M in transactions — all concentrated in Contineum Therapeutics, Inc. (CTNM). Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

1 loaded
Jan 30CTNM
Contineum Therapeutics, Inc.
Slover Peter TChief Financial OfficerAward$2.7M

1 filing